The Centers for Disease Control and Prevention has issued a health advisory regarding multidrug-resistant bacterial infections due to artificial tears from a brand of nonprescription eye drops.
At least 55 patients in 12 states have been diagnosed with multidrug-resistant bacterial infections possibly linked to EzriCare Artificial Tears, the Centers for Disease Control and Prevention said Wednesday.
The CDC said that the infections had caused one death, permanent vision loss, and hospitalization in a health alert on its website.
CDC laboratory testing identified the presence of the outbreak strain in opened EzriCare bottles with different lot numbers collected from two states.
Patients and healthcare providers should immediately discontinue using EzriCare artificial tears pending additional guidance from CDC and the FDA.
EzriCare said it has stopped distributing and selling the eye drops.
The infections were caused by Pseudomonas aeruginosa, the CDC said, a bacterium highly resistant to antibiotics.
The CDC advised people who have used EzriCare Artificial Tears and who have symptoms of infection such as eye discharge, pain, or discomfort to seek medical care.
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
This article Federal Agency Warns Outbreak Of Drug-Resistant Infections After Use Of OTC Artificial Tear Brand originally appeared on Benzinga.com
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.